(Q54722061)

3 June 2018

title

Value of new quinolones in the treatment and prophylaxis of infectious diseases: introductory remarks. (English)

1 reference

3 June 2018

0 references

J S Wolfson

1

1 reference

3 June 2018

B E Murray

series ordinal

2

1 reference

3 June 2018

publication date

1 December 1989

1 reference

3 June 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

3 June 2018

volume

8

1 reference

3 June 2018

issue

12

1 reference

3 June 2018

page(s)

1071-1074

1 reference

3 June 2018

https://scigraph.springernature.com/pub.10.1007/bf01975173

exact match

0 references

cites work

Structure-activity relationships of the fluoroquinolones

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

In vitro activity of PD 127,391, an enhanced-spectrum quinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

Comparative in vitro activity of PD 127,391, a new fluorinated 4-quinolone derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

Difloxacin metabolism and pharmacokinetics in humans after single oral doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01975173

Aspects of chemistry in the development of the 4-quinolone antibacterial agents

21 January 2018

1 reference

12 December 2020

Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity

1 reference

12 December 2020

Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes

1 reference

12 December 2020

New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay

1 reference

12 December 2020

Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

1 reference

12 December 2020

Clinical use of the quinolones

1 reference

12 December 2020

Chiral DNA gyrase inhibitors. 1. Synthesis and antimicrobial activity of the enantiomers of 6-fluoro-7-(1-piperazinyl)-1-(2'-trans-phenyl-1'-cyclopropyl)-1, 4-dihydro-4-oxoquinoline-3-carboxylic acid

1 reference

12 December 2020

Comparative antibacterial activity of new quinolone-carboxylic acid derivatives

1 reference

12 December 2020

Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

1 reference

12 December 2020

DNA Gyrase and the Supercoiling of DNA

1 reference

12 December 2020

Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme

1 reference

12 December 2020

1 reference

12 December 2020

Mode of action of the quinolone antimicrobial agents.

1 reference

12 December 2020

1 reference

12 December 2020

DNA gyrase: an enzyme that introduces superhelical turns into DNA

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01975173

1 reference

3 June 2018

1 reference

3 June 2018